Island Pharmaceuticals

(ASX) ILA

Current PriceA$0.38

Market CapA$112.45M

Since IPO (2021)-22%

5 Year+12%

1 Year+105%

1 Month+21%

Island Pharmaceuticals Financials at a Glance

Market Cap

A$112.45M

Revenue (TTM)

A$421.43K

Net Income (TTM)

-A$10.44M

EPS (TTM)

-A$0.03

P/E Ratio

-12.30

Dividend

A$0.00

Beta (Volatility)

0.20 (Low)

Dividend

A$0.00

Beta (Volatility)

0.20 (Low)

Price

A$0.38

Volume

403,253

Open

A$0.37

Price

A$0.38

Volume

403,253

Open

A$0.37

Previous Close

A$0.38

Daily Range

A$0.35 - A$0.39

52-Week Range

A$0.13 - A$0.63

Estimated Earnings Date

Aug 27, 2026

Dividend

A$0.00

Beta (Volatility)

0.20 (Low)

Price

A$0.38

Volume

403,253

Open

A$0.37

Previous Close

A$0.38

Daily Range

A$0.35 - A$0.39

52-Week Range

A$0.13 - A$0.63

Estimated Earnings Date

Aug 27, 2026

ILA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Island Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

CEO

David Foster, PhD

Website

www.islandpharmaceuticals.com

Headquarters

Camberwell, VIC 3124, AU

ILA Financials

Key Financial Metrics (TTM)

Gross Margin

-33%

Operating Margin

-367%

Net Income Margin

-326%

Return on Equity

-130%

Return on Capital

-1%

Return on Assets

-90%

Earnings Yield

-8.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$112.45M

Shares Outstanding

295.92M

Volume

403.25K

Avg. Volume

267.48K

Financials (TTM)

Gross Profit

-A$1.29M

Operating Income

-A$5.36M

EBITDA

-A$4.07M

Operating Cash Flow

-A$2.77M

Capital Expenditure

A$5.00

Free Cash Flow

-A$2.77M

Cash & ST Invst.

A$7.25M

Total Debt

A$0.00

Island Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$52.65K

+83.6%

Gross Margin

0.00%

N/A

Market Cap

A$112.45M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-A$4.81M

-316.5%

EBITDA

-A$4.90M

-484.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$6.87M

+603.8%

Total Debt

A$0.00

-100.0%

Accounts Receivable

A$192.40K

-69.5%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

-100.0%

Return on Assets

-89.78%

N/A

Return on Invested Capital

-1.13%

N/A

Free Cash Flow

-A$1.98M

-46.2%

Operating Cash Flow

-A$1.98M

-46.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ATH.AXAlterity Therapeutics Limited

ATH.AXAlterity Therapeutics LimitedA$0.50+11.24%

ACW.AXActinogen Medical Limited

ACW.AXActinogen Medical LimitedA$0.03+0.00%

ALA.AXArovella Therapeutics Limited

ALA.AXArovella Therapeutics LimitedA$0.07+1.52%

RCE.AXRecce Pharmaceuticals Ltd

RCE.AXRecce Pharmaceuticals LtdA$0.50+2.04%

BIO.AXBiome Australia Limited

BIO.AXBiome Australia LimitedA$0.28+0.00%

ATX.AXAmplia Therapeutics Limited

ATX.AXAmplia Therapeutics LimitedA$0.11+0.00%

TRJ.AXTrajan Group Holdings Limited

TRJ.AXTrajan Group Holdings LimitedA$0.33+10.17%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About ILA

What is the current price of Island Pharmaceuticals?

Island Pharmaceuticals is trading at A$0.38 per share.

What is the 52-week range for Island Pharmaceuticals?

Over the past 52 weeks, Island Pharmaceuticals has traded between A$0.13 and A$0.63.

How much debt does Island Pharmaceuticals have?

As of the most recent reporting period, Island Pharmaceuticals reported total debt of A$0.00.

How much cash does Island Pharmaceuticals have on hand?

Island Pharmaceuticals reported A$7.25M in cash and cash equivalents in its most recent financial results.

What is Island Pharmaceuticals’s dividend yield?

Island Pharmaceuticals does not currently have a dividend yield.

Island Pharmaceuticals

Island Pharmaceuticals Financials at a Glance

ILA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Island Pharmaceuticals

ILA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Island Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ILA

What is the current price of Island Pharmaceuticals?

What is the 52-week range for Island Pharmaceuticals?

How much debt does Island Pharmaceuticals have?

How much cash does Island Pharmaceuticals have on hand?

What is Island Pharmaceuticals’s dividend yield?

Premium Investing Services